| Dr Manish Kumar Sharma, MD | |
|
800 W Central Rd, Arlington Heights, IL 60005-2349 | |
| (877) 635-9229 | |
| (847) 618-3259 |
| Full Name | Dr Manish Kumar Sharma |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 15 Years |
| Location | 800 W Central Rd, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619280708 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 036134824 (Illinois) | Secondary |
| 207R00000X | Internal Medicine | A121417 (California) | Secondary |
| 208M00000X | Hospitalist | 036134824 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Community Hospital 1 | Arlington heights, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Community Health Services Inc | 3375737331 | 275 |
News Archive
One of the world's leading experts in bone marrow failure and related blood disorders recently joined The Children's Hospital of Philadelphia. Hematology researcher Monica Bessler, M.D., Ph.D., arrived at the hospital this summer to establish a new program, the Pediatric and Adult Comprehensive Bone Marrow Failure Center.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
In this analysis, "IRIN discussed with aid agencies and Sahel food security analysts the subtleties of getting early warning messages right in such situations."
While attending a conference at the Universidad Nacional Autónoma de México in Mexico City several years ago, Sharon Borja was struck by the story of a young man who, as a child, joined his parents repatriating to their native country of Mexico. Like millions of Mexican immigrants, the family had called the United States home for years, and having been born in the U.S., he was an American citizen.
› Verified 7 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
One of the world's leading experts in bone marrow failure and related blood disorders recently joined The Children's Hospital of Philadelphia. Hematology researcher Monica Bessler, M.D., Ph.D., arrived at the hospital this summer to establish a new program, the Pediatric and Adult Comprehensive Bone Marrow Failure Center.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
In this analysis, "IRIN discussed with aid agencies and Sahel food security analysts the subtleties of getting early warning messages right in such situations."
While attending a conference at the Universidad Nacional Autónoma de México in Mexico City several years ago, Sharon Borja was struck by the story of a young man who, as a child, joined his parents repatriating to their native country of Mexico. Like millions of Mexican immigrants, the family had called the United States home for years, and having been born in the U.S., he was an American citizen.
› Verified 7 days ago
| Entity Name | Northwest Community Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134433154 PECOS PAC ID: 3375737331 Enrollment ID: O20101103000837 |
News Archive
One of the world's leading experts in bone marrow failure and related blood disorders recently joined The Children's Hospital of Philadelphia. Hematology researcher Monica Bessler, M.D., Ph.D., arrived at the hospital this summer to establish a new program, the Pediatric and Adult Comprehensive Bone Marrow Failure Center.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
In this analysis, "IRIN discussed with aid agencies and Sahel food security analysts the subtleties of getting early warning messages right in such situations."
While attending a conference at the Universidad Nacional Autónoma de México in Mexico City several years ago, Sharon Borja was struck by the story of a young man who, as a child, joined his parents repatriating to their native country of Mexico. Like millions of Mexican immigrants, the family had called the United States home for years, and having been born in the U.S., he was an American citizen.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manish Kumar Sharma, MD 800 W Central Rd, Arlington Heights, IL 60005-2349 Ph: (877) 635-9229 | Dr Manish Kumar Sharma, MD 800 W Central Rd, Arlington Heights, IL 60005-2349 Ph: (877) 635-9229 |
News Archive
One of the world's leading experts in bone marrow failure and related blood disorders recently joined The Children's Hospital of Philadelphia. Hematology researcher Monica Bessler, M.D., Ph.D., arrived at the hospital this summer to establish a new program, the Pediatric and Adult Comprehensive Bone Marrow Failure Center.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
In this analysis, "IRIN discussed with aid agencies and Sahel food security analysts the subtleties of getting early warning messages right in such situations."
While attending a conference at the Universidad Nacional Autónoma de México in Mexico City several years ago, Sharon Borja was struck by the story of a young man who, as a child, joined his parents repatriating to their native country of Mexico. Like millions of Mexican immigrants, the family had called the United States home for years, and having been born in the U.S., he was an American citizen.
› Verified 7 days ago
Dr. Doron Galili, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-227-8987 | |
Rushabh Shah, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 877-635-9229 Fax: 847-618-3259 | |
Ahtesham Hyder, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 877-635-9229 Fax: 847-618-3259 | |
Ayham Alagha, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 877-635-9229 Fax: 847-618-3259 |